Basic Information
Basic information for MIR9-3HG-253-10aa
Peptide Name MIR9-3HG-253-10aa
Genome Position chr15:89396363-89396392[+]
Species Human
Peptide Sequence MALFTLWAYL
Peptide Length 10
Unique No (MIR9-3HG-201-10aa,MIR9-3HG-202-10aa,MIR9-3HG-203-10aa,MIR9-3HG-205-10aa,MIR9-3HG-212-10aa,MIR9-3HG-213-10aa,MIR9-3HG-214-10aa,MIR9-3HG-218-10aa,MIR9-3HG-219-10aa,MIR9-3HG-220-10aa,MIR9-3HG-221-10aa,MIR9-3HG-222-10aa,MIR9-3HG-224-10aa,MIR9-3HG-225-10aa,MIR9-3HG-226-10aa,MIR9-3HG-227-10aa,MIR9-3HG-229-10aa,MIR9-3HG-233-10aa,MIR9-3HG-241-10aa,MIR9-3HG-242-10aa,MIR9-3HG-244-10aa,MIR9-3HG-246-10aa-2,MIR9-3HG-247-10aa,MIR9-3HG-248-10aa,MIR9-3HG-249-10aa,MIR9-3HG-251-10aa,MIR9-3HG-252-10aa)
Grand Average of Hydropathicity 1.68
Relative Molecular Mass 1390.66
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000671447;MIR9-3HG-253
Transcript Length 4989
Coding Ability 0.47
DNA Sequence Corresponding to Peptide ATGGCACTATTTACTCTGTGGGCATATTTG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :